nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—PTGS1—Alzheimer's disease	0.256	0.595	CbGaD
Zafirlukast—CYP2D6—Alzheimer's disease	0.174	0.405	CbGaD
Zafirlukast—CYP2D6—Rivastigmine—Alzheimer's disease	0.0674	0.179	CbGbCtD
Zafirlukast—CYP2C19—Memantine—Alzheimer's disease	0.0614	0.164	CbGbCtD
Zafirlukast—CYP2C9—Donepezil—Alzheimer's disease	0.0589	0.157	CbGbCtD
Zafirlukast—CYP2D6—Donepezil—Alzheimer's disease	0.0539	0.143	CbGbCtD
Zafirlukast—CYP3A4—Rivastigmine—Alzheimer's disease	0.0428	0.114	CbGbCtD
Zafirlukast—CYP2D6—Galantamine—Alzheimer's disease	0.0347	0.0924	CbGbCtD
Zafirlukast—CYP3A4—Donepezil—Alzheimer's disease	0.0342	0.0912	CbGbCtD
Zafirlukast—CYP3A4—Galantamine—Alzheimer's disease	0.0221	0.0588	CbGbCtD
Zafirlukast—Upset stomach—Galantamine—Alzheimer's disease	0.00272	0.0216	CcSEcCtD
Zafirlukast—Raised liver function tests—Memantine—Alzheimer's disease	0.00272	0.0215	CcSEcCtD
Zafirlukast—Raised liver function tests—Rivastigmine—Alzheimer's disease	0.00266	0.0211	CcSEcCtD
Zafirlukast—Upset stomach—Donepezil—Alzheimer's disease	0.00211	0.0167	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Galantamine—Alzheimer's disease	0.00197	0.0156	CcSEcCtD
Zafirlukast—Throat sore—Donepezil—Alzheimer's disease	0.00192	0.0152	CcSEcCtD
Zafirlukast—Oropharyngeal discomfort—Donepezil—Alzheimer's disease	0.0019	0.0151	CcSEcCtD
Zafirlukast—Haematemesis—Rivastigmine—Alzheimer's disease	0.00177	0.014	CcSEcCtD
Zafirlukast—Glyburide—ABCA1—Alzheimer's disease	0.00175	0.673	CrCbGaD
Zafirlukast—Blister—Rivastigmine—Alzheimer's disease	0.0017	0.0135	CcSEcCtD
Zafirlukast—Haemoptysis—Memantine—Alzheimer's disease	0.0017	0.0134	CcSEcCtD
Zafirlukast—Numbness—Donepezil—Alzheimer's disease	0.00167	0.0132	CcSEcCtD
Zafirlukast—Sensory loss—Donepezil—Alzheimer's disease	0.0016	0.0126	CcSEcCtD
Zafirlukast—Contusion—Donepezil—Alzheimer's disease	0.00158	0.0126	CcSEcCtD
Zafirlukast—Accidental injury—Donepezil—Alzheimer's disease	0.00156	0.0124	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Donepezil—Alzheimer's disease	0.00153	0.0121	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Donepezil—Alzheimer's disease	0.00152	0.012	CcSEcCtD
Zafirlukast—Oropharyngeal pain—Donepezil—Alzheimer's disease	0.00152	0.012	CcSEcCtD
Zafirlukast—Numbness—Memantine—Alzheimer's disease	0.00151	0.012	CcSEcCtD
Zafirlukast—Sensory loss—Memantine—Alzheimer's disease	0.00145	0.0115	CcSEcCtD
Zafirlukast—Accidental injury—Memantine—Alzheimer's disease	0.00142	0.0112	CcSEcCtD
Zafirlukast—Injury—Galantamine—Alzheimer's disease	0.00141	0.0112	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Memantine—Alzheimer's disease	0.00139	0.011	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Memantine—Alzheimer's disease	0.00138	0.0109	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Rivastigmine—Alzheimer's disease	0.00136	0.0108	CcSEcCtD
Zafirlukast—Vasculitis—Rivastigmine—Alzheimer's disease	0.00126	0.00997	CcSEcCtD
Zafirlukast—Influenza like illness—Memantine—Alzheimer's disease	0.00122	0.00966	CcSEcCtD
Zafirlukast—Influenza like illness—Rivastigmine—Alzheimer's disease	0.00119	0.00945	CcSEcCtD
Zafirlukast—Neuropathy—Memantine—Alzheimer's disease	0.00118	0.00934	CcSEcCtD
Zafirlukast—Neuropathy—Rivastigmine—Alzheimer's disease	0.00115	0.00913	CcSEcCtD
Zafirlukast—Injury—Donepezil—Alzheimer's disease	0.00109	0.00865	CcSEcCtD
Zafirlukast—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00107	0.0085	CcSEcCtD
Zafirlukast—Dermatitis bullous—Donepezil—Alzheimer's disease	0.00105	0.00832	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Memantine—Alzheimer's disease	0.00104	0.00826	CcSEcCtD
Zafirlukast—Hepatic failure—Memantine—Alzheimer's disease	0.00101	0.00803	CcSEcCtD
Zafirlukast—Injury—Memantine—Alzheimer's disease	0.000991	0.00785	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.000978	0.00775	CcSEcCtD
Zafirlukast—Injury—Rivastigmine—Alzheimer's disease	0.00097	0.00768	CcSEcCtD
Zafirlukast—Dermatitis bullous—Memantine—Alzheimer's disease	0.000953	0.00755	CcSEcCtD
Zafirlukast—Dermatitis bullous—Rivastigmine—Alzheimer's disease	0.000932	0.00739	CcSEcCtD
Zafirlukast—Liver function test abnormal—Donepezil—Alzheimer's disease	0.000926	0.00734	CcSEcCtD
Zafirlukast—Haemoglobin—Galantamine—Alzheimer's disease	0.0009	0.00713	CcSEcCtD
Zafirlukast—Haemorrhage—Galantamine—Alzheimer's disease	0.000896	0.0071	CcSEcCtD
Zafirlukast—Hepatitis—Galantamine—Alzheimer's disease	0.000896	0.0071	CcSEcCtD
Zafirlukast—Eosinophilia—Donepezil—Alzheimer's disease	0.000859	0.0068	CcSEcCtD
Zafirlukast—Encainide—CYP2D6—Alzheimer's disease	0.000847	0.327	CrCbGaD
Zafirlukast—Liver function test abnormal—Memantine—Alzheimer's disease	0.000841	0.00667	CcSEcCtD
Zafirlukast—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000831	0.00659	CcSEcCtD
Zafirlukast—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.000823	0.00652	CcSEcCtD
Zafirlukast—Back pain—Galantamine—Alzheimer's disease	0.000754	0.00598	CcSEcCtD
Zafirlukast—Jaundice—Donepezil—Alzheimer's disease	0.000754	0.00597	CcSEcCtD
Zafirlukast—Neutropenia—Memantine—Alzheimer's disease	0.000736	0.00583	CcSEcCtD
Zafirlukast—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000723	0.00573	CcSEcCtD
Zafirlukast—Malaise—Galantamine—Alzheimer's disease	0.000703	0.00557	CcSEcCtD
Zafirlukast—Haemoglobin—Donepezil—Alzheimer's disease	0.000698	0.00553	CcSEcCtD
Zafirlukast—Haemorrhage—Donepezil—Alzheimer's disease	0.000694	0.0055	CcSEcCtD
Zafirlukast—Hepatitis—Donepezil—Alzheimer's disease	0.000694	0.0055	CcSEcCtD
Zafirlukast—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000691	0.00547	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000688	0.00545	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000673	0.00534	CcSEcCtD
Zafirlukast—Myalgia—Galantamine—Alzheimer's disease	0.000664	0.00526	CcSEcCtD
Zafirlukast—Arthralgia—Galantamine—Alzheimer's disease	0.000664	0.00526	CcSEcCtD
Zafirlukast—Sinusitis—Memantine—Alzheimer's disease	0.000659	0.00522	CcSEcCtD
Zafirlukast—Discomfort—Galantamine—Alzheimer's disease	0.000656	0.0052	CcSEcCtD
Zafirlukast—Agranulocytosis—Memantine—Alzheimer's disease	0.000655	0.00519	CcSEcCtD
Zafirlukast—Sinusitis—Rivastigmine—Alzheimer's disease	0.000644	0.00511	CcSEcCtD
Zafirlukast—Haemoglobin—Memantine—Alzheimer's disease	0.000633	0.00502	CcSEcCtD
Zafirlukast—Haemorrhage—Memantine—Alzheimer's disease	0.00063	0.00499	CcSEcCtD
Zafirlukast—Hepatitis—Memantine—Alzheimer's disease	0.00063	0.00499	CcSEcCtD
Zafirlukast—Hypoaesthesia—Memantine—Alzheimer's disease	0.000627	0.00497	CcSEcCtD
Zafirlukast—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000623	0.00494	CcSEcCtD
Zafirlukast—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00062	0.00491	CcSEcCtD
Zafirlukast—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000617	0.00489	CcSEcCtD
Zafirlukast—Hepatitis—Rivastigmine—Alzheimer's disease	0.000617	0.00489	CcSEcCtD
Zafirlukast—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000613	0.00486	CcSEcCtD
Zafirlukast—Back pain—Donepezil—Alzheimer's disease	0.000584	0.00463	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00058	0.00459	CcSEcCtD
Zafirlukast—Insomnia—Galantamine—Alzheimer's disease	0.000576	0.00456	CcSEcCtD
Zafirlukast—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000561	0.00444	CcSEcCtD
Zafirlukast—Dyspepsia—Galantamine—Alzheimer's disease	0.00056	0.00444	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000549	0.00435	CcSEcCtD
Zafirlukast—Fatigue—Galantamine—Alzheimer's disease	0.000549	0.00435	CcSEcCtD
Zafirlukast—Malaise—Donepezil—Alzheimer's disease	0.000545	0.00432	CcSEcCtD
Zafirlukast—Back pain—Memantine—Alzheimer's disease	0.000531	0.00421	CcSEcCtD
Zafirlukast—Feeling abnormal—Galantamine—Alzheimer's disease	0.000524	0.00416	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00052	0.00412	CcSEcCtD
Zafirlukast—Back pain—Rivastigmine—Alzheimer's disease	0.000519	0.00411	CcSEcCtD
Zafirlukast—Arthralgia—Donepezil—Alzheimer's disease	0.000514	0.00408	CcSEcCtD
Zafirlukast—Myalgia—Donepezil—Alzheimer's disease	0.000514	0.00408	CcSEcCtD
Zafirlukast—Ill-defined disorder—Memantine—Alzheimer's disease	0.000509	0.00403	CcSEcCtD
Zafirlukast—Discomfort—Donepezil—Alzheimer's disease	0.000508	0.00403	CcSEcCtD
Zafirlukast—Abdominal pain—Galantamine—Alzheimer's disease	0.000503	0.00399	CcSEcCtD
Zafirlukast—Body temperature increased—Galantamine—Alzheimer's disease	0.000503	0.00399	CcSEcCtD
Zafirlukast—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000498	0.00395	CcSEcCtD
Zafirlukast—Malaise—Memantine—Alzheimer's disease	0.000495	0.00392	CcSEcCtD
Zafirlukast—Oedema—Donepezil—Alzheimer's disease	0.000493	0.00391	CcSEcCtD
Zafirlukast—Infection—Donepezil—Alzheimer's disease	0.00049	0.00388	CcSEcCtD
Zafirlukast—Malaise—Rivastigmine—Alzheimer's disease	0.000484	0.00384	CcSEcCtD
Zafirlukast—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000483	0.00383	CcSEcCtD
Zafirlukast—Hypersensitivity—Galantamine—Alzheimer's disease	0.000469	0.00372	CcSEcCtD
Zafirlukast—Myalgia—Memantine—Alzheimer's disease	0.000467	0.0037	CcSEcCtD
Zafirlukast—Arthralgia—Memantine—Alzheimer's disease	0.000467	0.0037	CcSEcCtD
Zafirlukast—Discomfort—Memantine—Alzheimer's disease	0.000461	0.00366	CcSEcCtD
Zafirlukast—Arthralgia—Rivastigmine—Alzheimer's disease	0.000457	0.00362	CcSEcCtD
Zafirlukast—Myalgia—Rivastigmine—Alzheimer's disease	0.000457	0.00362	CcSEcCtD
Zafirlukast—Asthenia—Galantamine—Alzheimer's disease	0.000457	0.00362	CcSEcCtD
Zafirlukast—Discomfort—Rivastigmine—Alzheimer's disease	0.000451	0.00358	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000449	0.00356	CcSEcCtD
Zafirlukast—Oedema—Memantine—Alzheimer's disease	0.000448	0.00355	CcSEcCtD
Zafirlukast—Insomnia—Donepezil—Alzheimer's disease	0.000446	0.00353	CcSEcCtD
Zafirlukast—Infection—Memantine—Alzheimer's disease	0.000445	0.00353	CcSEcCtD
Zafirlukast—Thrombocytopenia—Memantine—Alzheimer's disease	0.000438	0.00347	CcSEcCtD
Zafirlukast—Oedema—Rivastigmine—Alzheimer's disease	0.000438	0.00347	CcSEcCtD
Zafirlukast—Diarrhoea—Galantamine—Alzheimer's disease	0.000435	0.00345	CcSEcCtD
Zafirlukast—Infection—Rivastigmine—Alzheimer's disease	0.000435	0.00345	CcSEcCtD
Zafirlukast—Dyspepsia—Donepezil—Alzheimer's disease	0.000434	0.00344	CcSEcCtD
Zafirlukast—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000429	0.0034	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000426	0.00337	CcSEcCtD
Zafirlukast—Fatigue—Donepezil—Alzheimer's disease	0.000425	0.00337	CcSEcCtD
Zafirlukast—Pain—Donepezil—Alzheimer's disease	0.000422	0.00334	CcSEcCtD
Zafirlukast—Dizziness—Galantamine—Alzheimer's disease	0.000421	0.00333	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000408	0.00323	CcSEcCtD
Zafirlukast—Feeling abnormal—Donepezil—Alzheimer's disease	0.000406	0.00322	CcSEcCtD
Zafirlukast—Insomnia—Memantine—Alzheimer's disease	0.000405	0.00321	CcSEcCtD
Zafirlukast—Vomiting—Galantamine—Alzheimer's disease	0.000405	0.00321	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000403	0.0032	CcSEcCtD
Zafirlukast—Rash—Galantamine—Alzheimer's disease	0.000401	0.00318	CcSEcCtD
Zafirlukast—Dermatitis—Galantamine—Alzheimer's disease	0.000401	0.00318	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000399	0.00316	CcSEcCtD
Zafirlukast—Headache—Galantamine—Alzheimer's disease	0.000399	0.00316	CcSEcCtD
Zafirlukast—Insomnia—Rivastigmine—Alzheimer's disease	0.000396	0.00314	CcSEcCtD
Zafirlukast—Dyspepsia—Memantine—Alzheimer's disease	0.000394	0.00312	CcSEcCtD
Zafirlukast—Urticaria—Donepezil—Alzheimer's disease	0.000392	0.0031	CcSEcCtD
Zafirlukast—Body temperature increased—Donepezil—Alzheimer's disease	0.00039	0.00309	CcSEcCtD
Zafirlukast—Abdominal pain—Donepezil—Alzheimer's disease	0.00039	0.00309	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000387	0.00306	CcSEcCtD
Zafirlukast—Fatigue—Memantine—Alzheimer's disease	0.000386	0.00306	CcSEcCtD
Zafirlukast—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000386	0.00306	CcSEcCtD
Zafirlukast—Pain—Memantine—Alzheimer's disease	0.000383	0.00303	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000378	0.003	CcSEcCtD
Zafirlukast—Nausea—Galantamine—Alzheimer's disease	0.000378	0.003	CcSEcCtD
Zafirlukast—Fatigue—Rivastigmine—Alzheimer's disease	0.000378	0.00299	CcSEcCtD
Zafirlukast—Pain—Rivastigmine—Alzheimer's disease	0.000375	0.00297	CcSEcCtD
Zafirlukast—Feeling abnormal—Memantine—Alzheimer's disease	0.000369	0.00292	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000366	0.0029	CcSEcCtD
Zafirlukast—Hypersensitivity—Donepezil—Alzheimer's disease	0.000363	0.00288	CcSEcCtD
Zafirlukast—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000361	0.00286	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000358	0.00284	CcSEcCtD
Zafirlukast—Urticaria—Memantine—Alzheimer's disease	0.000356	0.00282	CcSEcCtD
Zafirlukast—Body temperature increased—Memantine—Alzheimer's disease	0.000354	0.00281	CcSEcCtD
Zafirlukast—Abdominal pain—Memantine—Alzheimer's disease	0.000354	0.00281	CcSEcCtD
Zafirlukast—Asthenia—Donepezil—Alzheimer's disease	0.000354	0.0028	CcSEcCtD
Zafirlukast—Pruritus—Donepezil—Alzheimer's disease	0.000349	0.00276	CcSEcCtD
Zafirlukast—Urticaria—Rivastigmine—Alzheimer's disease	0.000348	0.00276	CcSEcCtD
Zafirlukast—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000346	0.00274	CcSEcCtD
Zafirlukast—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000346	0.00274	CcSEcCtD
Zafirlukast—Diarrhoea—Donepezil—Alzheimer's disease	0.000337	0.00267	CcSEcCtD
Zafirlukast—Hypersensitivity—Memantine—Alzheimer's disease	0.00033	0.00261	CcSEcCtD
Zafirlukast—Dizziness—Donepezil—Alzheimer's disease	0.000326	0.00258	CcSEcCtD
Zafirlukast—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000323	0.00256	CcSEcCtD
Zafirlukast—Asthenia—Memantine—Alzheimer's disease	0.000321	0.00255	CcSEcCtD
Zafirlukast—Pruritus—Memantine—Alzheimer's disease	0.000317	0.00251	CcSEcCtD
Zafirlukast—Asthenia—Rivastigmine—Alzheimer's disease	0.000314	0.00249	CcSEcCtD
Zafirlukast—Vomiting—Donepezil—Alzheimer's disease	0.000314	0.00248	CcSEcCtD
Zafirlukast—Rash—Donepezil—Alzheimer's disease	0.000311	0.00246	CcSEcCtD
Zafirlukast—Dermatitis—Donepezil—Alzheimer's disease	0.000311	0.00246	CcSEcCtD
Zafirlukast—Pruritus—Rivastigmine—Alzheimer's disease	0.00031	0.00246	CcSEcCtD
Zafirlukast—Headache—Donepezil—Alzheimer's disease	0.000309	0.00245	CcSEcCtD
Zafirlukast—Diarrhoea—Memantine—Alzheimer's disease	0.000306	0.00243	CcSEcCtD
Zafirlukast—Diarrhoea—Rivastigmine—Alzheimer's disease	0.0003	0.00238	CcSEcCtD
Zafirlukast—Dizziness—Memantine—Alzheimer's disease	0.000296	0.00235	CcSEcCtD
Zafirlukast—Nausea—Donepezil—Alzheimer's disease	0.000293	0.00232	CcSEcCtD
Zafirlukast—Dizziness—Rivastigmine—Alzheimer's disease	0.00029	0.0023	CcSEcCtD
Zafirlukast—Vomiting—Memantine—Alzheimer's disease	0.000285	0.00226	CcSEcCtD
Zafirlukast—Rash—Memantine—Alzheimer's disease	0.000282	0.00224	CcSEcCtD
Zafirlukast—Dermatitis—Memantine—Alzheimer's disease	0.000282	0.00224	CcSEcCtD
Zafirlukast—Headache—Memantine—Alzheimer's disease	0.000281	0.00222	CcSEcCtD
Zafirlukast—Vomiting—Rivastigmine—Alzheimer's disease	0.000279	0.00221	CcSEcCtD
Zafirlukast—Rash—Rivastigmine—Alzheimer's disease	0.000276	0.00219	CcSEcCtD
Zafirlukast—Dermatitis—Rivastigmine—Alzheimer's disease	0.000276	0.00219	CcSEcCtD
Zafirlukast—Headache—Rivastigmine—Alzheimer's disease	0.000274	0.00217	CcSEcCtD
Zafirlukast—Nausea—Memantine—Alzheimer's disease	0.000266	0.00211	CcSEcCtD
Zafirlukast—Nausea—Rivastigmine—Alzheimer's disease	0.00026	0.00206	CcSEcCtD
Zafirlukast—CYP2E1—Metabolism—MAOB—Alzheimer's disease	1.39e-05	0.000209	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CYP2D6—Alzheimer's disease	1.38e-05	0.000208	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.37e-05	0.000207	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.36e-05	0.000205	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—BCHE—Alzheimer's disease	1.36e-05	0.000205	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ND1—Alzheimer's disease	1.35e-05	0.000203	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GAPDH—Alzheimer's disease	1.33e-05	0.000201	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.33e-05	0.000201	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.32e-05	0.000199	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—BCHE—Alzheimer's disease	1.31e-05	0.000197	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.29e-05	0.000195	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—A2M—Alzheimer's disease	1.29e-05	0.000194	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PLCB1—Alzheimer's disease	1.28e-05	0.000193	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.26e-05	0.000189	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CHAT—Alzheimer's disease	1.25e-05	0.000188	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—TPI1—Alzheimer's disease	1.25e-05	0.000188	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CASP3—Alzheimer's disease	1.24e-05	0.000188	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ABCA1—Alzheimer's disease	1.24e-05	0.000188	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL6—Alzheimer's disease	1.24e-05	0.000186	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PLCB1—Alzheimer's disease	1.23e-05	0.000186	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.22e-05	0.000185	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.22e-05	0.000183	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.21e-05	0.000183	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.21e-05	0.000182	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.21e-05	0.000182	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—MAOB—Alzheimer's disease	1.2e-05	0.000181	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ABCA1—Alzheimer's disease	1.2e-05	0.00018	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.17e-05	0.000176	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	1.15e-05	0.000174	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TP53—Alzheimer's disease	1.15e-05	0.000173	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MAPK8—Alzheimer's disease	1.14e-05	0.000172	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—AKT1—Alzheimer's disease	1.14e-05	0.000172	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.14e-05	0.000172	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.13e-05	0.00017	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ACHE—Alzheimer's disease	1.12e-05	0.000169	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.12e-05	0.000169	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TPI1—Alzheimer's disease	1.12e-05	0.000168	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CHAT—Alzheimer's disease	1.12e-05	0.000168	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—A2M—Alzheimer's disease	1.11e-05	0.000168	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—INPP5D—Alzheimer's disease	1.11e-05	0.000167	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.11e-05	0.000167	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.08e-05	0.000162	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PPARGC1A—Alzheimer's disease	1.07e-05	0.000162	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—MAOB—Alzheimer's disease	1.07e-05	0.000161	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—HMOX1—Alzheimer's disease	1.07e-05	0.000161	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—VEGFA—Alzheimer's disease	1.06e-05	0.000159	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL6—Alzheimer's disease	1.05e-05	0.000159	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS1—Alzheimer's disease	1.05e-05	0.000158	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ENO1—Alzheimer's disease	1.05e-05	0.000158	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.04e-05	0.000157	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.04e-05	0.000157	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PPARGC1A—Alzheimer's disease	1.03e-05	0.000155	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP2D6—Alzheimer's disease	1.03e-05	0.000155	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	1.03e-05	0.000155	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.03e-05	0.000155	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.03e-05	0.000155	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—HMOX1—Alzheimer's disease	1.03e-05	0.000155	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.02e-05	0.000153	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.02e-05	0.000153	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.02e-05	0.000153	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.01e-05	0.000152	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—A2M—Alzheimer's disease	9.94e-06	0.00015	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.93e-06	0.00015	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—MAOB—Alzheimer's disease	9.84e-06	0.000148	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—BCHE—Alzheimer's disease	9.77e-06	0.000147	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—LPL—Alzheimer's disease	9.76e-06	0.000147	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—MAOB—Alzheimer's disease	9.75e-06	0.000147	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—AKT1—Alzheimer's disease	9.72e-06	0.000146	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TGFB1—Alzheimer's disease	9.69e-06	0.000146	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ACHE—Alzheimer's disease	9.69e-06	0.000146	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	9.58e-06	0.000144	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	9.47e-06	0.000143	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	9.46e-06	0.000143	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	9.39e-06	0.000141	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—LPL—Alzheimer's disease	9.38e-06	0.000141	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	9.28e-06	0.00014	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PLCB1—Alzheimer's disease	9.21e-06	0.000139	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	9.19e-06	0.000139	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—A2M—Alzheimer's disease	9.14e-06	0.000138	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	9.08e-06	0.000137	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ENO1—Alzheimer's disease	9.08e-06	0.000137	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—A2M—Alzheimer's disease	9.06e-06	0.000137	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ABCA1—Alzheimer's disease	8.93e-06	0.000135	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	8.9e-06	0.000134	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	8.86e-06	0.000134	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—MTHFR—Alzheimer's disease	8.79e-06	0.000132	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CHAT—Alzheimer's disease	8.69e-06	0.000131	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TPI1—Alzheimer's disease	8.69e-06	0.000131	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ACHE—Alzheimer's disease	8.65e-06	0.00013	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	8.55e-06	0.000129	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—MTHFR—Alzheimer's disease	8.44e-06	0.000127	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—BCHE—Alzheimer's disease	8.44e-06	0.000127	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—MAOB—Alzheimer's disease	8.33e-06	0.000126	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CALM1—Alzheimer's disease	8.21e-06	0.000124	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—APOE—Alzheimer's disease	8.18e-06	0.000123	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CAV1—Alzheimer's disease	8.11e-06	0.000122	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	8.1e-06	0.000122	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ENO1—Alzheimer's disease	8.1e-06	0.000122	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	8.08e-06	0.000122	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	8.02e-06	0.000121	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TP53—Alzheimer's disease	7.98e-06	0.00012	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	7.96e-06	0.00012	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ACHE—Alzheimer's disease	7.95e-06	0.00012	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	7.95e-06	0.00012	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	7.93e-06	0.00012	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CALM1—Alzheimer's disease	7.89e-06	0.000119	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ACHE—Alzheimer's disease	7.89e-06	0.000119	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	7.86e-06	0.000119	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—APOE—Alzheimer's disease	7.86e-06	0.000118	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	7.86e-06	0.000118	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.81e-06	0.000118	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	7.79e-06	0.000117	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CAV1—Alzheimer's disease	7.79e-06	0.000117	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—A2M—Alzheimer's disease	7.75e-06	0.000117	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	7.72e-06	0.000116	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	7.7e-06	0.000116	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	7.66e-06	0.000116	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—BCHE—Alzheimer's disease	7.53e-06	0.000114	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ENO1—Alzheimer's disease	7.45e-06	0.000112	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	7.45e-06	0.000112	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	7.39e-06	0.000111	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ENO1—Alzheimer's disease	7.39e-06	0.000111	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL6—Alzheimer's disease	7.3e-06	0.00011	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	7.25e-06	0.000109	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PPARG—Alzheimer's disease	7.13e-06	0.000107	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	7.11e-06	0.000107	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—LPL—Alzheimer's disease	7.01e-06	0.000106	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—INS—Alzheimer's disease	6.99e-06	0.000105	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.97e-06	0.000105	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—BCHE—Alzheimer's disease	6.93e-06	0.000104	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	6.91e-06	0.000104	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	6.89e-06	0.000104	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—BCHE—Alzheimer's disease	6.87e-06	0.000104	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PPARG—Alzheimer's disease	6.85e-06	0.000103	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ACHE—Alzheimer's disease	6.74e-06	0.000102	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AKT1—Alzheimer's disease	6.74e-06	0.000102	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—INS—Alzheimer's disease	6.72e-06	0.000101	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TPI1—Alzheimer's disease	6.71e-06	0.000101	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CHAT—Alzheimer's disease	6.71e-06	0.000101	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	6.66e-06	0.0001	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	6.65e-06	0.0001	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	6.62e-06	9.98e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	6.54e-06	9.86e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	6.48e-06	9.77e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MAOB—Alzheimer's disease	6.43e-06	9.69e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.36e-06	9.58e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	6.34e-06	9.55e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ENO1—Alzheimer's disease	6.31e-06	9.52e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	6.31e-06	9.52e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	6.31e-06	9.51e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	6.28e-06	9.47e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	6.19e-06	9.33e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	6.19e-06	9.33e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—NOS3—Alzheimer's disease	6.13e-06	9.24e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—LPL—Alzheimer's disease	6.06e-06	9.13e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—A2M—Alzheimer's disease	5.98e-06	9.01e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	5.94e-06	8.95e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	5.91e-06	8.91e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CALM1—Alzheimer's disease	5.9e-06	8.89e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—NOS3—Alzheimer's disease	5.89e-06	8.88e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—APOE—Alzheimer's disease	5.87e-06	8.86e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—BCHE—Alzheimer's disease	5.87e-06	8.85e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CAV1—Alzheimer's disease	5.82e-06	8.77e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTGS2—Alzheimer's disease	5.61e-06	8.45e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	5.54e-06	8.35e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	5.46e-06	8.23e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	5.45e-06	8.22e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	5.44e-06	8.2e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.43e-06	8.19e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	5.42e-06	8.16e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—LPL—Alzheimer's disease	5.41e-06	8.15e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	5.39e-06	8.13e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTGS2—Alzheimer's disease	5.39e-06	8.12e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	5.37e-06	8.09e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ACHE—Alzheimer's disease	5.2e-06	7.84e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	5.14e-06	7.75e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PPARG—Alzheimer's disease	5.12e-06	7.71e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CALM1—Alzheimer's disease	5.1e-06	7.68e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—APOE—Alzheimer's disease	5.08e-06	7.65e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CAV1—Alzheimer's disease	5.03e-06	7.58e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—INS—Alzheimer's disease	5.02e-06	7.56e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—LPL—Alzheimer's disease	4.97e-06	7.5e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—LPL—Alzheimer's disease	4.93e-06	7.43e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.87e-06	7.35e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.87e-06	7.35e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	4.87e-06	7.34e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.78e-06	7.2e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	4.63e-06	6.98e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	4.61e-06	6.94e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CALM1—Alzheimer's disease	4.55e-06	6.86e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—APOE—Alzheimer's disease	4.53e-06	6.83e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.53e-06	6.83e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CAV1—Alzheimer's disease	4.49e-06	6.77e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.48e-06	6.75e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	4.44e-06	6.69e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPARG—Alzheimer's disease	4.42e-06	6.67e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—NOS3—Alzheimer's disease	4.4e-06	6.63e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—INS—Alzheimer's disease	4.34e-06	6.54e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.27e-06	6.44e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—LPL—Alzheimer's disease	4.21e-06	6.35e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.18e-06	6.31e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.17e-06	6.28e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CALM1—Alzheimer's disease	4.15e-06	6.25e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4.14e-06	6.25e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—APOE—Alzheimer's disease	4.13e-06	6.23e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CAV1—Alzheimer's disease	4.13e-06	6.23e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CAV1—Alzheimer's disease	4.09e-06	6.17e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	4.03e-06	6.07e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPARG—Alzheimer's disease	3.95e-06	5.95e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—INS—Alzheimer's disease	3.87e-06	5.84e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—NOS3—Alzheimer's disease	3.8e-06	5.73e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	3.79e-06	5.72e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.63e-06	5.47e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPARG—Alzheimer's disease	3.6e-06	5.43e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.57e-06	5.38e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—INS—Alzheimer's disease	3.56e-06	5.37e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.56e-06	5.36e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CALM1—Alzheimer's disease	3.54e-06	5.34e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—APOE—Alzheimer's disease	3.53e-06	5.32e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—INS—Alzheimer's disease	3.53e-06	5.32e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CAV1—Alzheimer's disease	3.5e-06	5.27e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	3.48e-06	5.24e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—NOS3—Alzheimer's disease	3.4e-06	5.12e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.25e-06	4.9e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.12e-06	4.71e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	3.11e-06	4.68e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NOS3—Alzheimer's disease	3.1e-06	4.67e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPARG—Alzheimer's disease	3.08e-06	4.64e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—INS—Alzheimer's disease	3.02e-06	4.55e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.93e-06	4.41e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.86e-06	4.31e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	2.83e-06	4.27e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKT1—Alzheimer's disease	2.82e-06	4.25e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.74e-06	4.12e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.73e-06	4.11e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKT1—Alzheimer's disease	2.71e-06	4.08e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.7e-06	4.07e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NOS3—Alzheimer's disease	2.65e-06	3.99e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	2.42e-06	3.65e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.37e-06	3.58e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—INS—Alzheimer's disease	2.33e-06	3.51e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.04e-06	3.08e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKT1—Alzheimer's disease	2.02e-06	3.05e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.87e-06	2.82e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKT1—Alzheimer's disease	1.75e-06	2.64e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.56e-06	2.35e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.44e-06	2.16e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.42e-06	2.15e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.22e-06	1.83e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKT1—Alzheimer's disease	9.39e-07	1.41e-05	CbGpPWpGaD
